Back
Royal Bank of Canada Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
67
RY
Royal Bank of Canada
Last Price:
$119.49
Seasonality Move:
2.6%
Buy
61
RYTM
Rhythm Pharmaceuticals
Last Price:
$65.39
Seasonality Move:
15.42%
Buy
67
Royal Bank of Canada (RY)
is a Buy
Is Royal Bank of Canada a Buy, Sell or Hold?
-
The current Royal Bank of Canada [RY] share price is $118.58. The Score for RY is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
RY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $64.41. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RY Stock Price Chart
What is Royal Bank of Canada's stock price today?
-
The Royal Bank of Canada share price today is $118.58Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $64.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
RY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.98 | Buy |
| Relative Strength Index (14 RSI): | 59.41 | Buy |
| Chaikin Money Flow: | 804982 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (111.85 - 117.33) | Buy |
| Bollinger Bands (100): | (114.07 - 122.93) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.45 | Buy |
| Relative Strength Index (14 RSI): | 64.7 | Buy |
| Chaikin Money Flow: | 293034 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (52.38 - 61.8) | Buy |
| Bollinger Bands (100): | (53.02 - 59.98) | Buy |
RY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 117.11 | Buy |
| 20-day SMA: | 114.45 | Buy |
| 50-day SMA: | 115.12 | Buy |
| 200-day SMA: | 118.5 | Buy |
| 8-day EMA: | 117.03 | Buy |
| 20-day EMA: | 115.55 | Buy |
| 50-day EMA: | 115.78 | Buy |
| 200-day EMA: | 115.61 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.72 | Buy |
| 20-day SMA: | 57.9 | Buy |
| 50-day SMA: | 55.41 | Buy |
| 200-day SMA: | 53.57 | Buy |
| 8-day EMA: | 61.88 | Buy |
| 20-day EMA: | 59.19 | Buy |
| 50-day EMA: | 56.94 | Buy |
| 200-day EMA: | 52.74 | Buy |
Royal Bank of Canada Earnings Growth & RY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.19 per share, an increase this year of $1.06 per share, and an increase next year of $0.67 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
Royal Bank of Canada Technical Analysis
| Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||